Published in J Clin Invest on June 01, 1991
Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J (1994) 2.12
Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism. EMBO J (1994) 0.79
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature (1973) 15.28
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
The p53 proto-oncogene can act as a suppressor of transformation. Cell (1989) 11.67
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science (1990) 10.59
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (1985) 8.32
p53: a frequent target for genetic abnormalities in lung cancer. Science (1989) 7.51
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell (1984) 4.78
Characterization of the human p53 gene. Mol Cell Biol (1986) 4.33
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst (1960) 4.15
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science (1986) 3.53
Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1984) 3.24
Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci U S A (1985) 3.15
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol (1985) 3.09
In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A (1987) 3.03
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature (1985) 2.98
Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene (1988) 2.71
Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science (1986) 2.33
Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell (1987) 2.27
Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences. Mol Cell Biol (1984) 2.00
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A (1989) 1.86
Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood (1989) 1.85
Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science (1987) 1.76
Mutations in N-ras predominate in acute myeloid leukemia. Blood (1987) 1.68
Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science (1984) 1.44
Transforming genes in chronic myelogenous leukemia. Proc Natl Acad Sci U S A (1988) 1.30
Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood (1989) 1.09
The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood (1990) 1.08
bcr-abl RNA in patients with chronic myelogenous leukemia. Blood (1987) 1.07
Specificity of proto-oncogene amplification in human malignant diseases. Mol Biol Med (1987) 1.07
Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia. Lancet (1984) 1.05
Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features. Am J Clin Pathol (1984) 1.03
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood (1990) 0.97
A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation. Br J Haematol (1990) 0.93
Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia. Hum Genet (1981) 0.79
Molecular biology of chronic myelogenous leukemia. Semin Hematol (1988) 0.77
Ph-negative chronic myeloid leukaemia. Br J Haematol (1987) 0.76
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
Why Americans eat what they do: taste, nutrition, cost, convenience, and weight control concerns as influences on food consumption. J Am Diet Assoc (1998) 4.65
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
Medical care costs of patients with AIDS in San Francisco. JAMA (1986) 3.85
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med (1992) 3.64
Interprofessional education: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2008) 3.22
Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. Br J Pharmacol (1986) 3.07
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med (1996) 3.01
Genomic exclusion: a rapid means for inducing homozygous diploid lines in Tetrahymena pyriformis, syngen 1. Science (1967) 2.86
Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75
Increased incidence of asthma in children of smoking mothers. Pediatrics (1992) 2.53
Cytogenetics of genomic exclusion in Tetrahymena. Genetics (1967) 2.45
Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood (1991) 2.35
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res (2000) 2.22
Predicting protein structure using hidden Markov models. Proteins (1997) 2.20
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med (1989) 2.16
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol (1997) 2.15
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Concepts and terminology of apical dominance. Am J Bot (1997) 2.05
An unfortunate case of allergy to latex. Lancet (2000) 2.04
What is the value added by human intervention in protein structure prediction? Proteins (2001) 1.97
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Leukemia (2006) 1.95
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A (1989) 1.86
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia (2004) 1.84
Vocal cord dysfunction and wheezing. Thorax (1991) 1.82
Experimental tests for protrusion and undulation pressures in phospholipid bilayers. Biochemistry (1995) 1.78
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol (1982) 1.78
Predicting protein structure using only sequence information. Proteins (1999) 1.77
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect (2014) 1.71
Leukoencephalopathy and raised brain lactate from heroin vapor inhalation ("chasing the dragon") Neurology (1999) 1.70
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Electrophysiological and other aspects of the relaxant action of isoprenaline in guinea-pig isolated trachealis. Br J Pharmacol (1985) 1.69
Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood (1991) 1.69
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. Eur J Cancer (2005) 1.67
Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program. J Natl Cancer Inst (1989) 1.65
The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions. J Clin Rheumatol (2001) 1.61
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol (1996) 1.60
Feasibility testing of an automated image-capture method to aid dietary recall. Eur J Clin Nutr (2011) 1.59
Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet (2001) 1.57
p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A (1991) 1.56
Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J (1998) 1.56
Genetic and epigenetic control of several isozymic systems in Tetrahymena. Ann N Y Acad Sci (1968) 1.55
Use of minisatellite DNA probes for recognition and characterization of relapse after allogeneic bone marrow transplantation. Br J Haematol (1988) 1.54
Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res (1997) 1.51
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res (2000) 1.49
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood (2001) 1.47
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica (1997) 1.47
Temperature dependence of the repulsive pressure between phosphatidylcholine bilayers. Biophys J (1995) 1.47
Measurement of neutrino oscillation with KamLAND: evidence of spectral distortion. Phys Rev Lett (2005) 1.46
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43
Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest (2001) 1.43
The preparation of congenic strains of Tetrahymena. J Protozool (1971) 1.43
Arsenic and Ayurveda. Leuk Lymphoma (1993) 1.43
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood (2001) 1.38
Measurement of the nucleon strange-antistrange asymmetry at next-to-leading order in QCD from NuTeV Dimuon data. Phys Rev Lett (2007) 1.38
Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res (1995) 1.38
CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem (1998) 1.37
Protecting privacy to improve health care. Health Aff (Millwood) (1999) 1.36
Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res (1981) 1.33
Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem (1998) 1.33
Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene (2007) 1.33
Intersyngenic variations in the esterases of bacterized Paramecium aurelia. Biochem Genet (1971) 1.30
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc Natl Acad Sci U S A (2000) 1.27
The relaxant action of nicorandil in guinea-pig isolated trachealis. Br J Pharmacol (1986) 1.27
Mechanical and electrical aspects of the relaxant action of aminophylline in guinea-pig isolated trachealis. Br J Pharmacol (1986) 1.27
Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene (1996) 1.27
Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris. J Invest Dermatol (1978) 1.26
A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam Appl Toxicol (1989) 1.26
Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia. J Clin Invest (1980) 1.26
PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma. Oncogene (1999) 1.25
Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig (1998) 1.24
Inconsistency and institutional review boards. JAMA (1982) 1.24
Doctor-patient communications in a private family practice. J Fam Pract (1976) 1.24
Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res (1993) 1.23
Steroid-induced ocular hypertension in patients with filtering blebs. Ophthalmology (1980) 1.23
Phospholipid metabolism by phagocytic cells. VI. Observations on the fate of phospholipids of granulocytes and ingested Escherichia coli during phagocytosis. Biochim Biophys Acta (1972) 1.22
Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22
Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. J Immunol (1999) 1.20
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood (1980) 1.18
The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med (1991) 1.18
Hypoglossal nerve palsy in infectious mononucleosis. Neurology (1978) 1.18
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med (1995) 1.17
The effects of the dihydropyridine Bay K 8644 in guinea-pig isolated trachealis. Br J Pharmacol (1985) 1.17
Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res (1996) 1.15
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol (2001) 1.15
Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res (1999) 1.13
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol (1988) 1.13
Psychological and hormonal changes in the course of in vitro fertilization. J Assist Reprod Genet (1992) 1.13
Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest (1979) 1.11
Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol Cell Biochem (2000) 1.11
The 5S ribosomal RNA gene clusters in Tetrahymena thermophila: strain differences, chromosomal localization, and loss during micronuclear ageing. Mol Gen Genet (1984) 1.11
Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab (1995) 1.11
Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Ann Neurol (2000) 1.10
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol (1997) 1.10
The Neugebauer-Le Fort operation: a review of 118 partial colpocleises. Eur J Obstet Gynecol Reprod Biol (1981) 1.09
Zinc binding, circular dichroism, and equilibrium sedimentation studies on insulin (bovine) and several of its derivatives. Biochemistry (1974) 1.09
Heat and mechanical hyperalgesia induced by capsaicin. Cross modality threshold modulation in human C nociceptors. Brain (1989) 1.09
Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood (1989) 1.09